Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;326:1460 (28 June), doi:10.1136/bmj.326.7404.1460
| The first 150 words of the full text of this article appear below. |
EDITORThe systematic review by Raghunath et al was rigorous and well intentioned.1 However, their conclusion that the prevalence of Helicobacter pylori infection was significantly lower in patients with than without gastro-oesophageal reflux disease may be potentially misleading. The pooled control group in the meta-analysis was heterogeneous and consisted of asymptomatic subjects as well as patients with functional dyspepsia, anaemia, diarrhoea, or chest pain. What would be the clinical relevance of such a comparison?
It would probably have made more sense to pool the studies that used asymptomatic subjects as controls.24 The pooled odds ratio would have been 0.57 (95% confidence interval 0.24 to 1.39; random effects model used due to significant heterogeneity). The (cautious) conclusion would have been that the prevalence of H pylori infection in patients with gastrooesophageal reflux disease does not differ significantly from the prevalence in asymptomatic controls.
Meta-analyses of observational studies may produce very
Grigoris I Leontiadis, senior clinical fellow in gastroenterology
grleo@yahoo.com
Savvas Kadis, consultant gastroenterologist
Queen Elizabeth Hospital, Gateshead, Tyne and Wear NE9 6SX
Virender K Sharma, senior associate consultant
Division of Gastroenterology, Mayo Clinic, Scottsdale, Arizona, USA
Colin W Howden, professor of medicine
Division of Gastroenterology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA